Eisai shares long-term data on lecanemab at neurology congress

13th November 2025 Uncategorised 0

48-month analysis shows delayed progression and reduced risk in early Alzheimer’s patients

More: Eisai shares long-term data on lecanemab at neurology congress
Source: News